• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺与不安腿综合征中的脊髓:脊髓生理学是否揭示了增敏现象的基础?

Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?

作者信息

Paulus Walter, Schomburg Eike D

机构信息

Department of Clinical Neurophysiology, University of Göttingen, Robert Koch Str. 40, 37075 Göttingen, Germany.

出版信息

Sleep Med Rev. 2006 Jun;10(3):185-96. doi: 10.1016/j.smrv.2006.01.004.

DOI:10.1016/j.smrv.2006.01.004
PMID:16762808
Abstract

The pathophysiology of restless legs syndrome (RLS) is incompletely understood. L-DOPA, as the precursor of dopamine, as well as dopamine agonists, plays an essential role in the treatment of RLS leading to the assumption of a key role of dopamine function in the pathophysiology of RLS. Periodic limb movements in sleep are a key feature of RLS. They are generated in the spinal cord. Here we review RLS phenomenology on the basis of known dopaminergic influence on spinal control, which has been studied a great deal in recent decades in animals. In particular, we propose that the differential effects of l-DOPA and opioids on early and late flexor reflexes may be linked to the phenomenon of augmentation.

摘要

不安腿综合征(RLS)的病理生理学尚未完全明确。左旋多巴作为多巴胺的前体,以及多巴胺激动剂,在RLS的治疗中发挥着重要作用,这使得人们推测多巴胺功能在RLS的病理生理学中起关键作用。睡眠期周期性肢体运动是RLS的一个关键特征。它们在脊髓中产生。在此,我们基于已知的多巴胺能对脊髓控制的影响来综述RLS的现象学,近几十年来在动物身上对此进行了大量研究。特别是,我们提出左旋多巴和阿片类药物对早期和晚期屈肌反射的不同作用可能与症状加重现象有关。

相似文献

1
Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?多巴胺与不安腿综合征中的脊髓:脊髓生理学是否揭示了增敏现象的基础?
Sleep Med Rev. 2006 Jun;10(3):185-96. doi: 10.1016/j.smrv.2006.01.004.
2
Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.不宁腿综合征:从脊髓角度重新审视多巴胺假说。
Neurology. 2006 Jul 11;67(1):125-30. doi: 10.1212/01.wnl.0000223316.53428.c9.
3
Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.少即是多:不宁腿综合征中多巴胺能治疗相关增敏的病理生理学
Lancet Neurol. 2006 Oct;5(10):878-86. doi: 10.1016/S1474-4422(06)70576-2.
4
Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.多巴胺与阿片类药物的交汇之处:不安腿综合征治疗研究中安慰剂效应的荟萃分析。
Brain. 2008 Apr;131(Pt 4):902-17. doi: 10.1093/brain/awm244. Epub 2007 Oct 11.
5
Restless legs syndrome.不宁腿综合征
J Intern Med. 2009 Nov;266(5):419-31. doi: 10.1111/j.1365-2796.2009.02159.x.
6
Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.A11核6-羟基多巴胺损伤及饮食铁缺乏小鼠脊髓多巴胺受体的表达与功能
J Neurosci Res. 2007 Apr;85(5):1065-76. doi: 10.1002/jnr.21207.
7
Treatment of restless legs syndrome.治疗不宁腿综合征。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S65-70. doi: 10.1016/S1353-8020(09)70838-7.
8
Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.不宁腿综合征多巴胺能增强的诊断标准:马克斯·普朗克研究所世界睡眠医学协会-国际不宁腿综合征研究小组共识会议报告
Sleep Med. 2007 Aug;8(5):520-30. doi: 10.1016/j.sleep.2007.03.022. Epub 2007 Jun 1.
9
Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.在门诊护理环境中多巴胺激动剂和左旋多巴在不安腿综合征中的合理应用。
Ann Pharmacother. 2008 May;42(5):627-32. doi: 10.1345/aph.1K667. Epub 2008 Apr 1.
10
[L-dopa, dopamine agonists, opiates... what calms down restless legs].
MMW Fortschr Med. 2005 Feb 24;147(8):6, 8.

引用本文的文献

1
Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.不安腿综合征两种小鼠模型脊髓中多巴胺D1和D3受体的差异调节与表达
Front Behav Neurosci. 2018 Sep 4;12:199. doi: 10.3389/fnbeh.2018.00199. eCollection 2018.
2
The effects of long-term dopaminergic treatment on locomotor behavior in rats.长期多巴胺能治疗对大鼠运动行为的影响。
Sleep Sci. 2014 Dec;7(4):203-8. doi: 10.1016/j.slsci.2014.10.003. Epub 2014 Nov 12.
3
Microstructure of the Midbrain and Cervical Spinal Cord in Idiopathic Restless Legs Syndrome: A Diffusion Tensor Imaging Study.
特发性不宁腿综合征中脑和颈脊髓的微观结构:一项扩散张量成像研究
Sleep. 2016 Feb 1;39(2):423-8. doi: 10.5665/sleep.5456.
4
Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.不宁腿综合征中与多巴胺能治疗相关的冲动控制行为的频率。
BMC Neurol. 2011 Sep 28;11:117. doi: 10.1186/1471-2377-11-117.
5
Drug-induced sleep: theoretical and practical considerations.药物诱导睡眠:理论与实际的考虑因素。
Pflugers Arch. 2012 Jan;463(1):177-86. doi: 10.1007/s00424-011-1033-3. Epub 2011 Sep 28.
6
Dopamine agonists for restless legs syndrome.用于治疗不宁腿综合征的多巴胺激动剂。
Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD006009. doi: 10.1002/14651858.CD006009.pub2.
7
Restless legs syndrome: pathophysiology, clinical presentation and management.不宁腿综合征:病理生理学、临床表现和治疗。
Nat Rev Neurol. 2010 Jun;6(6):337-46. doi: 10.1038/nrneurol.2010.55.
8
Refractory restless legs syndrome likely caused by olanzapine.难治性不宁腿综合征可能由奥氮平引起。
J Clin Sleep Med. 2009 Feb 15;5(1):68-9.
9
Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.不宁腿综合征:诊断评估及多巴胺能治疗的利弊
J Neurol. 2006 Aug;253 Suppl 4:IV22-8. doi: 10.1007/s00415-006-4005-3.